Briefly, all genes in SLC15A family could be used as clinical outcome prediction biomarkers in NSCLS, while SLC15A2 and SLC15A4 are with favorable prognostic value in lung adenocarcinoma. Here, SLC15A4 is linked to lung adenocarcinoma.